MMP-1 inhibition (recombinant enzyme)| Type of assay | Enzyme activity | | Biological model | Acellular | | Species | Human | | Endpoint | Human MMP-1 activity |
| BIOCH-0002 | Enzyme activity assays, ECM degradation | Enzyme activity | Acellular | Human | Human MMP-1 activity | Fluorescence | | |
MMP-9 inhibition (recombinant enzyme)| Type of assay | Enzyme activity | | Biological model | Acellular | | Species | Human | | Endpoint | Human MMP-9 activity |
| BIOCH-0003 | Enzyme activity assays, ECM degradation | Enzyme activity | Acellular | Human | Human MMP-9 activity | Fluorescence | | |
MMP inhibition (NHDF extracts)| Type of assay | Enzyme activity | | Biological model | Acellular | | Species | Human | | Endpoint | Human MMP activity (2 substrates)*, Human MMP-2 and MMP-7 activity, Human MMP-1, MMP-8, MMP-13 and MMP-14 activity |
| BIOCH-0004 | Enzyme activity assays, ECM degradation | Enzyme activity | Acellular | Human | Human MMP activity (2 substrates)*, Human MMP-2 and MMP-7 activity, Human MMP-1, MMP-8, MMP-13 and MMP-14 activity | Fluorescence | | |
Hyaluronidase inhibition (purified enzyme)| Type of assay | Enzyme activity | | Biological model | Acellular | | Species | Bovine | | Endpoint | Hyaluronidase activity |
| BIOCH-0005 | Enzyme activity assays, Epidermal matrix, hydration, ECM degradation | Enzyme activity | Acellular | Bovine | Hyaluronidase activity | Photometry | Basal | |
Leukocyte elastase inhibition (purified enzyme)| Type of assay | Enzyme activity | | Biological model | Acellular | | Species | Human | | Endpoint | Elastase activity (serine-type enzyme) |
| BIOCH-0006 | Enzyme activity assays, ECM degradation | Enzyme activity | Acellular | Human | Elastase activity (serine-type enzyme) | Fluorescence | | |
Collagenase inhibition (bacterial enzyme)| Type of assay | Enzyme activity | | Biological model | Acellular | | Species | | | Endpoint | Collagenase activity |
| BIOCH-0021 | Enzyme activity assays, ECM degradation | Enzyme activity | Acellular | | Collagenase activity | Fluorescence | | |
MMP-2 inhibition (recombinant enzyme)| Type of assay | Enzyme activity | | Biological model | Acellular | | Species | Human | | Endpoint | Human MMP-2 activity |
| BIOCH-0028 | Enzyme activity assays, ECM degradation | Enzyme activity | Acellular | Human | Human MMP-2 activity | Fluorescence | | |
DE, dermis strength and cohesion (basal)| Type of assay | Metabolism | | Biological model | Dermis-equivalent, normal fibroblasts | | Species | Human | | Endpoint | Lattices contraction |
| DE-0001 | Fibroblast viability & metabolism | Metabolism | Dermis-equivalent, normal fibroblasts | Human | Lattices contraction | Imaging | Basal | |
DE, hyaluronic acid synthesis/release (basal)| Type of assay | GAG synthesis | | Biological model | Dermis-equivalent, normal fibroblasts | | Species | Human | | Endpoint | Hyaluronic acid synthesis / release |
| DE-0006 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | GAG synthesis | Dermis-equivalent, normal fibroblasts | Human | Hyaluronic acid synthesis / release | ELISA / EIA | Basal | |
DE, total GAGs neosynthesis (basal)| Type of assay | GAG synthesis | | Biological model | Dermis-equivalent, normal fibroblasts | | Species | Human | | Endpoint | Glycosaminoglycans (GAGs, total) |
| DE-0008 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | GAG synthesis | Dermis-equivalent, normal fibroblasts | Human | Glycosaminoglycans (GAGs, total) | [3H]-glucosamine incorporation | Basal | |
DE, fibroblast & ECM-related gene expression (basal)| Type of assay | Gene expression | | Biological model | Dermis-equivalent, normal fibroblasts | | Species | Human | | Endpoint | mRNA: e.g. ECM-related genes,..., mQPA-NHDF-16, mQPA-NHDF-32, mQPA-NHDF-64 |
| DE-0010 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | Gene expression | Dermis-equivalent, normal fibroblasts | Human | mRNA: e.g. ECM-related genes,..., mQPA-NHDF-16, mQPA-NHDF-32, mQPA-NHDF-64 | RT-qPCR, qPCRarray (standard or customized) | Basal | |
NHDF, MMP-1 release (UV stimulation)| Type of assay | ECM synthesis/degradation | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | MMP-1 release |
| NHDF-0001 | ECM degradation, Photo-aging (dermis), Photo-aging, UV, solar (dermis) | ECM synthesis/degradation | Dermal fibroblasts (NHDF) | Human | MMP-1 release | ELISA / EIA | UVA | |
NHDF, proliferation (basal)| Type of assay | Proliferation and/or migration | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | Proliferation |
| NHDF-0003 | Fibroblast viability & metabolism, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | Proliferation and/or migration | Dermal fibroblasts (NHDF) | Human | Proliferation | [3H]-thymidine incorporation | Basal | |
NHDF, migration (basal)| Type of assay | Proliferation and/or migration | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | Migration, Migration (+ proliferation) |
| NHDF-0004 | Fibroblast viability & metabolism, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | Proliferation and/or migration | Dermal fibroblasts (NHDF) | Human | Migration, Migration (+ proliferation) | Fluorescence / imaging | Basal | |
NHDF, procollagen I synthesis/release (basal)| Type of assay | Protein markers | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | Procollagen I synthesis / release |
| NHDF-0006 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | Protein markers | Dermal fibroblasts (NHDF) | Human | Procollagen I synthesis / release | ELISA / EIA | Basal | |
NHDF, fibronectin synthesis/release (basal)| Type of assay | Protein markers | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | Fibronectin synthesis / release |
| NHDF-0007 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | Protein markers | Dermal fibroblasts (NHDF) | Human | Fibronectin synthesis / release | ELISA / EIA | Basal | |
NHDF, hyaluronic acid synthesis/release (basal)| Type of assay | GAG synthesis | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | Hyaluronic acid synthesis / release |
| NHDF-0008 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | GAG synthesis | Dermal fibroblasts (NHDF) | Human | Hyaluronic acid synthesis / release | ELISA / EIA | Basal | |
NHDF, total GAG synthesis (basal)| Type of assay | GAG synthesis | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | Glycosaminoglycans (GAGs, total) |
| NHDF-0009 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | GAG synthesis | Dermal fibroblasts (NHDF) | Human | Glycosaminoglycans (GAGs, total) | [3H]-glucosamine incorporation | Basal | |
NHDF, sulfated GAG synthesis (basal)| Type of assay | GAG synthesis | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | Sulfated glycosaminoglycans (sulfated GAGs) |
| NHDF-0010 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | GAG synthesis | Dermal fibroblasts (NHDF) | Human | Sulfated glycosaminoglycans (sulfated GAGs) | Sulfur-35 (35S) incorporation | Basal | |
NHDF, ECM gene expression (basal)| Type of assay | Gene expression | | Biological model | Dermal fibroblasts (NHDF) | | Species | Human | | Endpoint | ECM components mRNA, mQPA-NHDF-16, mQPA-NHDF-32, mQPA-NHDF-64 |
| NHDF-0011 | ECM synthesis, Wound healing, trauma & agressions, Wound healing, trauma & aggressions | Gene expression | Dermal fibroblasts (NHDF) | Human | ECM components mRNA, mQPA-NHDF-16, mQPA-NHDF-32, mQPA-NHDF-64 | RT-qPCR, qPCRarray (standard or customized) | Basal | |